PEG 3350 + electrolyte use effective, reduces costs

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1552, 2006-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Methylprednisolone: Anaphylaxis to PEG 3350 excipient: case report

Reactions Weekly, Vol. 1, Iss. 1427, 2012-01 ,pp. : 32-32

Adis International

Access to resources Recommend Favorite

Bisacodyl/PEG-3350: Colonic ischaemia: case report

Reactions Weekly, Vol. 1, Iss. 1340, 2011-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Intervention reduces fluoxetine use, costs in managed care

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 352, 2002-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Antibacterial monitoring intervention reduces use, costs

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 445, 2004-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Loss of bodyweight reduces drug use, costs in obesity

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 352, 2002-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite